Aligos Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aligos Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • Aligos Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $5.81M, a 20.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.81M -$1.5M -20.5% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $6.17M -$1.14M -15.6% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $6.56M -$1.14M -14.8% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $6.94M -$1.13M -14% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $7.31M -$1.13M -13.4% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $7.31M -$1.45M -16.6% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $7.7M -$1.09M -12.4% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $8.07M +$1.19M +17.2% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $8.44M +$1.64M +24.2% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $8.76M +$1.81M +26% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $8.79M +$1.89M +27.4% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $6.89M -$168K -2.38% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $6.8M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $6.95M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $6.9M -$669K -8.84% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $7.05M Sep 30, 2020 10-Q 2020-11-25
Q4 2019 $7.57M Dec 31, 2019 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.